BTBD7 Antikörper
-
- Target Alle BTBD7 Produkte
- BTBD7 (BTB (POZ) Domain Containing 7 (BTBD7))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BTBD7 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Verwendungszweck
- BTBD7 Rabbit pAb
- Kreuzreaktivität
- Human, Maus, Ratte
- Produktmerkmale
- Polyclonal Antibodies
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant protein of human BTBD7.
- Isotyp
- IgG
-
-
- Applikationshinweise
- WB,1:500 - 1:2000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- BTBD7 (BTB (POZ) Domain Containing 7 (BTBD7))
- Andere Bezeichnung
- BTBD7 (BTBD7 Produkte)
- Synonyme
- wu:fd08g07 antikoerper, si:dkeyp-55f12.1 antikoerper, FUP1 antikoerper, 5730507E09Rik antikoerper, 8030448M07 antikoerper, E130118E17Rik antikoerper, mKIAA1525 antikoerper, BTB (POZ) domain containing 7 antikoerper, BTB domain containing 7 antikoerper, btbd7 antikoerper, BTBD7 antikoerper, Btbd7 antikoerper
- Hintergrund
- Acts as a mediator of epithelial dynamics and organ branching by promoting cleft progression. Induced following accumulation of fibronectin in forming clefts, leading to local expression of the cell-scattering SNAIL2 and suppression of E-cadherin levels, thereby altering cell morphology and reducing cell-cell adhesion. This stimulates cell separation at the base of forming clefts by local, dynamic intercellular gap formation and promotes cleft progression (By similarity.,FUP1,BTBD7,Cancer,Tumor biomarkers,BTBD7
- Molekulargewicht
- 13kDa
- Gen-ID
- 55727
- UniProt
- Q9P203
-